Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe RNA Analysis Market, by Product
1.4.2 Europe RNA Analysis Market, by Technology
1.4.3 Europe RNA Analysis Market, by End-use
1.4.4 Europe RNA Analysis Market, by Application
1.4.5 Europe RNA Analysis Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenarios
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2022, Jun) Leading Players
Chapter 4. Europe RNA Analysis Market by Product
4.1 Europe Kits & Reagents Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Services Market by Country
Chapter 5. Europe RNA Analysis Market by Technology
5.1 Europe Real Time-PCR (qPCR) Technology Market by Country
5.2 Europe Sequencing Technology Market by Country
5.3 Europe Microarray Technology Market by Country
5.4 Europe Others Market by Country
Chapter 6. Europe RNA Analysis Market by End-use
6.1 Europe Government Institutes & Academic Centers Market by Country
6.2 Europe Hospitals & Clinics Market by Country
6.3 Europe Pharmaceutical & Biotechnology Companies Market by Country
6.4 Europe Contract Research Organizations (CROs) Market by Country
Chapter 7. Europe RNA Analysis Market by Application
7.1 Europe Infectious Diseases & Pathogenesis Market by Country
7.2 Europe Epigenetics Market by Country
7.3 Europe RNA Structure & Molecular Dynamics Market by Country
7.4 Europe Development & Delivery of RNA Therapeutics Market by Country
7.5 Europe Construction of RNA Expression Atlas Market by Country
7.6 Europe Alternative RNA Splicing Market by Country
7.7 Europe Others Market by Country
Chapter 8. Europe RNA Analysis Market by Country
8.1 Germany RNA Analysis Market
8.1.1 Germany RNA Analysis Market by Product
8.1.2 Germany RNA Analysis Market by Technology
8.1.3 Germany RNA Analysis Market by End-use
8.1.4 Germany RNA Analysis Market by Application
8.2 UK RNA Analysis Market
8.2.1 UK RNA Analysis Market by Product
8.2.2 UK RNA Analysis Market by Technology
8.2.3 UK RNA Analysis Market by End-use
8.2.4 UK RNA Analysis Market by Application
8.3 France RNA Analysis Market
8.3.1 France RNA Analysis Market by Product
8.3.2 France RNA Analysis Market by Technology
8.3.3 France RNA Analysis Market by End-use
8.3.4 France RNA Analysis Market by Application
8.4 Russia RNA Analysis Market
8.4.1 Russia RNA Analysis Market by Product
8.4.2 Russia RNA Analysis Market by Technology
8.4.3 Russia RNA Analysis Market by End-use
8.4.4 Russia RNA Analysis Market by Application
8.5 Spain RNA Analysis Market
8.5.1 Spain RNA Analysis Market by Product
8.5.2 Spain RNA Analysis Market by Technology
8.5.3 Spain RNA Analysis Market by End-use
8.5.4 Spain RNA Analysis Market by Application
8.6 Italy RNA Analysis Market
8.6.1 Italy RNA Analysis Market by Product
8.6.2 Italy RNA Analysis Market by Technology
8.6.3 Italy RNA Analysis Market by End-use
8.6.4 Italy RNA Analysis Market by Application
8.7 Rest of Europe RNA Analysis Market
8.7.1 Rest of Europe RNA Analysis Market by Product
8.7.2 Rest of Europe RNA Analysis Market by Technology
8.7.3 Rest of Europe RNA Analysis Market by End-use
8.7.4 Rest of Europe RNA Analysis Market by Application
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Acquisition and Mergers:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.5.5.2 Product Launches and Product Expansions:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Product Launches and Product Expansions:
9.9 Merck Group
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Acquisition and Mergers:
9.10. Promega Corporation
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions:
9.10.2.2 Geographical Expansions:
Unique Offerings 
